Sotorasib in advanced KRASG12C-mutated non-small cell lung cancer patients with comorbidities
Latest Information Update: 20 Feb 2024
At a glance
- Drugs Sotorasib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms SOLUCOM
- 08 Nov 2021 New trial record